Nantong JiangTian Chemical Co., Ltd. (SHE:300927)
China · Delayed Price · Currency is CNY 27.55
-0.74 (-2.62%)
May 19, 2026, 3:04 PM CST
SHE:300927 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,586 | 1,549 | 685.41 | 707.26 | 734.24 | 707.98 |
Other Revenue | 3.05 | 3.05 | 2.97 | 1.86 | 3.06 | 2 |
| 1,589 | 1,552 | 688.38 | 709.12 | 737.29 | 709.97 | |
Revenue Growth (YoY) | 83.20% | 125.51% | -2.93% | -3.82% | 3.85% | 62.20% |
Cost of Revenue | 1,474 | 1,452 | 582.35 | 569.15 | 605.2 | 568.03 |
Gross Profit | 115.44 | 100.09 | 106.03 | 139.97 | 132.1 | 141.94 |
Selling, General & Admin | 65.05 | 65.56 | 45.42 | 42.02 | 42.05 | 40.55 |
Research & Development | 11.26 | 9.93 | 5.08 | 8 | 6.39 | 6.86 |
Other Operating Expenses | 7.24 | 6.95 | 3.76 | 5.01 | 3.79 | 3.65 |
Operating Expenses | 85.97 | 83.99 | 54.45 | 54.88 | 52.25 | 51.22 |
Operating Income | 29.47 | 16.1 | 51.59 | 85.09 | 79.85 | 90.72 |
Interest Expense | -3.16 | -2.77 | -1.81 | -3.08 | -3.75 | -2.76 |
Interest & Investment Income | 4.07 | 4.41 | 6.27 | 5.27 | 4.72 | 1.69 |
Currency Exchange Gain (Loss) | 0.91 | 0.91 | 0.19 | 1.68 | 1.28 | -1.12 |
Other Non Operating Income (Expenses) | -1.87 | 0.61 | -0.37 | -0.53 | -0.14 | -2.43 |
EBT Excluding Unusual Items | 29.41 | 19.25 | 55.87 | 88.42 | 81.96 | 86.1 |
Gain (Loss) on Sale of Investments | 1.4 | 1.32 | -0.05 | -0.04 | 0.02 | 0.01 |
Gain (Loss) on Sale of Assets | - | - | - | 0.01 | - | - |
Asset Writedown | 0.01 | -0.05 | -0 | -0.03 | -0.03 | -0.22 |
Other Unusual Items | 1.94 | 1.94 | 255.29 | 0.98 | 0.62 | 2.24 |
Pretax Income | 33.74 | 23.44 | 311.11 | 89.34 | 82.57 | 88.12 |
Income Tax Expense | 2.16 | 3.93 | 13.37 | 20.79 | 18.77 | 12.3 |
Net Income | 31.58 | 19.51 | 297.74 | 68.55 | 63.79 | 75.83 |
Net Income to Common | 31.58 | 19.51 | 297.74 | 68.55 | 63.79 | 75.83 |
Net Income Growth | -88.96% | -93.45% | 334.35% | 7.45% | -15.87% | 37.85% |
Shares Outstanding (Basic) | 145 | 144 | 144 | 144 | 144 | 144 |
Shares Outstanding (Diluted) | 145 | 144 | 144 | 144 | 144 | 144 |
Shares Change (YoY) | 0.28% | 0.03% | -0.01% | 0.00% | 0.01% | 33.34% |
EPS (Basic) | 0.22 | 0.14 | 2.06 | 0.47 | 0.44 | 0.53 |
EPS (Diluted) | 0.22 | 0.14 | 2.06 | 0.47 | 0.44 | 0.53 |
EPS Growth | -88.99% | -93.45% | 334.39% | 7.45% | -15.88% | 3.38% |
Free Cash Flow | 3.12 | -6.21 | -250.55 | -39.94 | 64.34 | 31.78 |
Free Cash Flow Per Share | 0.02 | -0.04 | -1.74 | -0.28 | 0.45 | 0.22 |
Dividend Per Share | 0.075 | 0.075 | 0.090 | 0.145 | 0.135 | 0.160 |
Dividend Growth | -16.67% | -16.67% | -37.93% | 7.41% | -15.63% | 37.10% |
Gross Margin | 7.26% | 6.45% | 15.40% | 19.74% | 17.92% | 19.99% |
Operating Margin | 1.85% | 1.04% | 7.49% | 12.00% | 10.83% | 12.78% |
Profit Margin | 1.99% | 1.26% | 43.25% | 9.67% | 8.65% | 10.68% |
Free Cash Flow Margin | 0.20% | -0.40% | -36.40% | -5.63% | 8.73% | 4.48% |
EBITDA | 95.39 | 75.91 | 86.94 | 122.28 | 114.23 | 124.76 |
EBITDA Margin | 6.00% | 4.89% | 12.63% | 17.24% | 15.49% | 17.57% |
D&A For EBITDA | 65.92 | 59.81 | 35.35 | 37.19 | 34.38 | 34.04 |
EBIT | 29.47 | 16.1 | 51.59 | 85.09 | 79.85 | 90.72 |
EBIT Margin | 1.85% | 1.04% | 7.49% | 12.00% | 10.83% | 12.78% |
Effective Tax Rate | 6.41% | 16.78% | 4.30% | 23.27% | 22.74% | 13.95% |
Revenue as Reported | 1,589 | 1,552 | 688.38 | 709.12 | 737.29 | 709.97 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.